News
U of M opens new first-in-human clinical trial for the treatment of advanced solid tumors
The University of Minnesota has become the third location in the United States to open a promising cell-based cancer immunotherapy clinical trial for the treatment of advanced solid tumors. The multicentered trial is investigating the…
University of Minnesota discovery is now a first-in-human clinical trial for leukemia
Designer molecule will activate the patient's own immune cells to attack cancer
The discovery of tri-specific natural killer engagers (TriKE™), a combination protein that bridges an immune cell and a tumor cell to drive tumor cell killing…
Masonic Cancer Center, University of Minnesota is hosting the first-ever Cancer Center Community Impact Forum (CCCIF)
The Masonic Cancer Center, University of Minnesota is hosting the first-ever Cancer Center Community Impact Forum (CCCIF)Community engagement professionals, researchers, and clinicians from cancer centers nationwide, as well as the…
Dr. Villalta appointed Director of the Analytical Biochemistry Shared Resource
Peter Villalta, PhD, has been appointed as the Director of the Analytical Biochemistry Shared Resource at the Masonic Cancer Center. After spending over 20 years as the coordinator of the mass spectrometry facility (part of the Analytical…
Ruping Sun, PhD, Joins LMP, Masonic Cancer Center
The Department of Laboratory Medicine and Pathology announces the appointment of Ruping Sun to our faculty as an assistant professor effective August 31. Sun is a computational geneticist with a PhD degree in genetics who has been working…
Masonic Cancer Center saddened by loss of longtime friend and advocate, Judy Erdahl
The Masonic Cancer Center team is saddened by the loss of Judy Erdahl, a longtime friend, and an advocate of the cancer center.
Judy passed away this morning surrounded by loved ones after a lengthy battle with metastatic breast cancer.…
Emil Lou named Masonic Cancer Center CTO Medical Director
Emil Lou, MD, PhD, FACP, Assistant Professor of Medicine, Division of Hematology, Oncology, and Transplantation (HOT), has been appointed Medical Director of the Masonic Cancer Center Clinical Trials Office (CTO). This new role will begin…
UMN Researchers awarded Multi-Million Dollar Grant to Research Metastatic Breast Cancer
A team led by Reuben Harris, PhD, Professor in the Department of Biochemistry, Molecular Biology, and Biophysics (BMBB), and Douglas Yee, MD, Director of the Masonic Cancer Center, and Professor in the Department of Medicine and…
Shernan Holtan Named the Masonic Cancer Center CTO-CGI Medical Director
Shernan Holtan, MD, Associate Professor of Medicine, Division of Hematology, Oncology and Transplantation and a Hematologist/Oncologist with University of Minnesota Health, was appointed as the Medical Director of the Masonic Cancer Center…
Pioneering Neurosurgeon Andrew Venteicher Joins UMN Medical School Department of Neurosurgery and the Masonic Cancer Center
Distinguished surgeon-scientist, Andrew Venteicher, MD, PhD, has joined the University of Minnesota Medical School’s Department of Neurosurgery and the Masonic Cancer Center, where he will be leading key research initiatives in the…